It demonstrated that, for path_MLH1, path_MSH2, and path_MSH6 carriers, the risk of metachronous CRC was lower in those having extended compared with segmental resection, despite continued endoscopic surveillance. This evidence concerns the gene MSH6 and colorectal carcinoma.